Table 2.
Changes in diagnosis after disclosure of the amyloid PET results
Change in clinical diagnosis (%) | Change in [18F]FDG PET diagnosis (%) | Clinical vs. [18F]FDG PET | |
---|---|---|---|
All patients (n = 84) | 23 | 18 | n.s. |
Early onset (≤65 years; n = 36) | 22 | 11 | n.s. |
Late onset (>65 years; n = 48) | 23 | 23 | n.s. |
Early vs. late onset | n.s. | n.s. (p = 0.158) | |
Late onset, AUC consistent (n = 33) | 21 | 24 | n.s. |
Late onset, not AUC consistent (n = 15) | 27 | 20 | n.s. |
Late onset, consistent vs. not consistent | n.s. | n.s. |
AUC Appropriate Use Criteria, n.s. not significant